COVID-19 Immunopathology

The research highlighted in this feed investigates the immunopathology seen in severely ill COVID-19 patients, which often resembles the cytokine storm syndrome: uncontrolled immune activation generates excessive release of cytokines, resulting in hyperinflammation and multi-organ disease.

August 1, 2020
Review
Open Access

Role of Autophagy in Lung Inflammation

Frontiers in Immunology
Jacob D PainterOmid Akbari
August 2, 2020
Preprint

Impact of tocilizumab administration on mortality in severe COVID-19

MedRxiv : the Preprint Server for Health Sciences
A. TsaiLuigi Brunetti
July 31, 2020
Review
Open Access

SARS-CoV-2: characteristics and current advances in research

Virology Journal
Yicheng YangWei Zhao
July 31, 2020

The clinical characteristics and course of COVID-19 in hemodialysis patients

Hemodialysis International
Kubra Aydin BahatSerap Sert
August 2, 2020

Clinical outcomes of COVID-19 in Wuhan, China: a large cohort study

Annals of Intensive Care
Jiao LiuDechang Chen
July 30, 2020

SARS-CoV-2 infection pathogenesis is related to oxidative stress as a response to aggression

Medical Hypotheses
Rubens Cecchini, Alessandra Lourenço Cecchini
July 30, 2020
Review
Open Access

Coronavirus Disease 2019 (COVID-19): A Haematologist's Perspective

Acta Haematologica
Carmen Ka Man CheungRaymond Siu Ming Wong
August 3, 2020
Review
Open Access

Sars-CoV-2 in pregnancy: Why is it better than expected?

European Journal of Obstetrics, Gynecology, and Reproductive Biology
Tullio GhiTiziana Frusca
July 30, 2020
Review
Open Access

A Message from the Human Placenta: Structural and Immunomodulatory Defense against SARS-CoV-2

Cells
Nina-Naomi KreisJuping Yuan
August 3, 2020
Review

The pathophysiology of SARS-CoV-2: A suggested model and therapeutic approach

Life Sciences
Gerwyn MorrisMichael Berk
July 31, 2020

SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity

Journal for Immunotherapy of Cancer
Jia WeiJianfeng Zhou
August 2, 2020

IgGs drive COVID-19 myeloid hyperinflammation

Nature Reviews. Immunology
Matthew D Park
August 1, 2020
Open Access

Complement Inhibition in Coronavirus Disease (COVID)-19: A Neglected Therapeutic Option

Frontiers in Immunology
Philip F Stahel, Scott R Barnum
August 3, 2020

Adding Inflammation to the Perfect Cytokine Storm: Concerns Related to Extracorporeal Membrane Oxygenation for COVID-19 Patients

ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs
Dimitrios C AngourasDimitrios Dougenis

Sign up to follow this feed and discover related papers.

Related Feeds

AI-driven COVID-19 Management

Artificial intelligence (AI) offers a powerful new tool that could potentially be instrumental in controling and managing the SARS-CoV-2 virus. The papers in this feed report on the applications of AI to the current pandemic, which may be able to predict the location of the next outbreak, or facilitate new drug design.

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

COVID-19 Clinical Diagnosis

COVID-19 patients typically present with high fever and a persistent cough. This feed focuses on clinical diagnosis, including RT-PCR testing for the presence of SARS-CoV-2 and radiographic assessment of lungs.

COVID-19 Clinical Management

While most COVID-19 infections cause only mild to moderate symptoms, severely affected patients, such as those presenting with pneumonia, ARDS or septic shock, require hospitalization. This feed focuses on clinical management of patients using oxygen therapy, ventilation, and other treatment strategies, and covers some medical case reports.

COVID-19 Comorbidities

COVID-19 represents a particular challenge to people with serious chronic medical conditions such as diabetes, hypertension, cardiovascular disease, and chronic lung disease. Research into the intersection between comorbidities and COVID-19 is focusing on risks and treatment outcomes for these patients.

COVID-19 Complications

A growing number of complications associated with COVID-19 has been identified. This feed focuses primarily on cardiovascular and respiratory manifestations in severely ill patients.

COVID-19 Covalescent Plasma Therapy

Convalescent plasma therapy, where passive polyclonal antibody obtained from recovered patients are used to provide immediate immunity, has been tested in respiratory infections such as the 2009-2010 H1N1 influenza virus pandemic and the 2003 SARS-CoV-1 epidemic. This feed follows ongoing research efforts and clinical trials exploring covalescent plasma therapy as a potential treatment strategy for COVID-19.

COVID-19 Epidemiology and Demography

Epidemiological studies play a crucial role in understanding and managing the progression of COVID-19. Research followed in this feed includes studies of transmission dynamics and the change of the basic reproductive number (R) as new pubic health measures take effect.

COVID-19 Immune Response

Understanding the innate and acquired immune response to SARS-CoV-2 is essential for development of COVID-19 therapeutic treatment and design of prophylactic vaccines. This feed surfaces immunological studies, including studies into the cytokine storm that has been observed in severely ill patients.

COVID-19 Neurologic Manifestations

COVID-19 patients frequently have neurological symptoms, which are probably caused by the virus invading the central nervous system. Symptoms range from a loss of smell and taste to serious complications such as encephalitis, many of which are associated with poor prognosis. This feed follows the latest developments and research into the neurological complications associated with COVID-19.

© 2020 Meta ULC. All rights reserved
/feed-previews/covid-19-immunopathology/718c2c4e-a9c3-40c6-b6e9-5bab37fa1658